These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9572898)

  • 1. A potent, orally bioavailable benzazepinone growth hormone secretagogue.
    DeVita RJ; Bochis R; Frontier AJ; Kotliar A; Fisher MH; Schoen WR; Wyvratt MJ; Cheng K; Chan WW; Butler B; Jacks TM; Hickey GJ; Schleim KD; Leung K; Chen Z; Chiu SL; Feeney WP; Cunningham PK; Smith RG
    J Med Chem; 1998 May; 41(10):1716-28. PubMed ID: 9572898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
    Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclic structural variants of growth hormone secretagogue L-692,429.
    Lin P; Pisano JM; Schoen WR; Cheng K; Chan WW; Butler BS; Smith RG; Fisher MH; Wyvratt MJ
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3237-42. PubMed ID: 10576695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.
    Cheng K; Chan WW; Butler B; Wei L; Schoen WR; Wyvratt MJ; Fisher MH; Smith RG
    Endocrinology; 1993 Jun; 132(6):2729-31. PubMed ID: 8389289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).
    Schoen WR; Pisano JM; Prendergast K; Wyvratt MJ; Fisher MH; Cheng K; Chan WW; Butler B; Smith RG; Ball RG
    J Med Chem; 1994 Apr; 37(7):897-906. PubMed ID: 8151616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonpeptidyl growth hormone secretagogue.
    Smith RG; Cheng K; Schoen WR; Pong SS; Hickey G; Jacks T; Butler B; Chan WW; Chaung LY; Judith F
    Science; 1993 Jun; 260(5114):1640-3. PubMed ID: 8503009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel non-peptidyl growth hormone secretagogue.
    Cheng K; Chan WW; Butler B; Wei L; Smith RG
    Horm Res; 1993; 40(1-3):109-15. PubMed ID: 7905455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue.
    Yang L; Morriello G; Patchett AA; Leung K; Jacks T; Cheng K; Schleim KD; Feeney W; Chan WW; Chiu SH; Smith RG
    J Med Chem; 1998 Jul; 41(14):2439-41. PubMed ID: 9651148
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).
    Li J; Chen SY; Li JJ; Wang H; Hernandez AS; Tao S; Musial CM; Qu F; Swartz S; Chao ST; Flynn N; Murphy BJ; Slusarchyk DA; Seethala R; Yan M; Sleph P; Grover G; Smith MA; Beehler B; Giupponi L; Dickinson KE; Zhang H; Humphreys WG; Patel BP; Schwinden M; Stouch T; Cheng PT; Biller SA; Ewing WR; Gordon D; Robl JA; Tino JA
    J Med Chem; 2007 Nov; 50(24):5890-3. PubMed ID: 17973363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken.
    Geris KL; Hickey GJ; Berghman LR; Visser TJ; Kühn ER; Darras VM
    Gen Comp Endocrinol; 1998 Aug; 111(2):186-96. PubMed ID: 9679090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2003 May; 13(10):1817-20. PubMed ID: 12729672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel orally active growth hormone secretagogues.
    Hansen TK; Ankersen M; Hansen BS; Raun K; Nielsen KK; Lau J; Peschke B; Lundt BF; Thøgersen H; Johansen NL; Madsen K; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3705-14. PubMed ID: 9733496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.
    Hickey G; Jacks T; Judith F; Taylor J; Schoen WR; Krupa D; Cunningham P; Clark J; Smith RG
    Endocrinology; 1994 Feb; 134(2):695-701. PubMed ID: 8299565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905).
    Duffey MO; Vos TJ; Adams R; Alley J; Anthony J; Barrett C; Bharathan I; Bowman D; Bump NJ; Chau R; Cullis C; Driscoll DL; Elder A; Forsyth N; Frazer J; Guo J; Guo L; Hyer ML; Janowick D; Kulkarni B; Lai SJ; Lasky K; Li G; Li J; Liao D; Little J; Peng B; Qian MG; Reynolds DJ; Rezaei M; Scott MP; Sells TB; Shinde V; Shi QJ; Sintchak MD; Soucy F; Sprott KT; Stroud SG; Nestor M; Visiers I; Weatherhead G; Ye Y; D'Amore N
    J Med Chem; 2012 Jan; 55(1):197-208. PubMed ID: 22070629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of ghrelin on isolated porcine somatotropes.
    Glavaski-Joksimovic A; Jeftinija K; Scanes CG; Anderson LL; Jeftinija S
    Neuroendocrinology; 2003 Jun; 77(6):367-79. PubMed ID: 12845223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.
    Jacks T; Smith R; Judith F; Schleim K; Frazier E; Chen H; Krupa D; Hora D; Nargund R; Patchett A; Hickey G
    Endocrinology; 1996 Dec; 137(12):5284-9. PubMed ID: 8940347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New highly potent dipeptidic growth hormone secretagogues with low molecular weight.
    Peschke B; Ankersen M; Hansen TK; Hansen BS; Lau J; Nielsen KK; Raun K
    Eur J Med Chem; 2000 Jun; 35(6):599-618. PubMed ID: 10906412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.